Alexandria Real Estate Equities, Inc (ARE) Stock Analysis

Verdict: AVOID

Severe asset write-downs and life science space oversupply override ARE's deep 0.55x P/B discount, signaling ongoing earnings dilution.

Investment score: 34/100

Analysis as of

Is Alexandria Real Estate Equities, Inc stock worth reviewing? AI model thesis

The AI model recommends AVOID for Alexandria Real Estate Equities (ARE). Despite trading at a 45% discount to book value (P/B 0.55x), the REIT suffers from severe net losses (-$1.43B in 2025), negative operating margins (-45.7%), and excessive leverage (Net Debt/EBITDA 29.83x). Consensus estimates project top-line revenue shrinking over 40% into 2026, making the current yield unsustainable.

7-factor investment score

Alexandria Real Estate Equities, Inc opportunities and risks

What speaks for ARE

What speaks against ARE

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
AREn/a3.0x50.9x69.5%-30.6%9.7%
DOC59.9x4.9x13.0x2.5%8.6%2.0%
OHI15.9x10.6x12.2x72.0%66.4%6.6%
AHR81.6x4.6x28.8x14.9%4.8%2.3%
JAN7093.0x15.5x32.8x1.5%10.1%0.0%
CTRE24.2x17.0x19.6x78.0%65.4%4.7%
Peer median59.9x10.6x19.6x14.9%10.1%2.3%

Frequently asked questions about Alexandria Real Estate Equities, Inc (ARE)

Is ARE stock a good investment?

The cached TradeMates AI model rates Alexandria Real Estate Equities, Inc as AVOID with an investment score of 34/100. The AI model recommends AVOID for Alexandria Real Estate Equities (ARE). Despite trading at a 45% discount to book value (P/B 0.55x), the REIT suffers from severe net losses (-$1.43B in 2025), negative operating margins (-45.7%), and excessive leverage (Net Debt/EBITDA 29.83x). Consensus estimates project top-line revenue shrinking over 40% into 2026, making the current yield unsustainable. This is algorithmic model output, not personal investment advice.

Is ARE stock a buy?

The TradeMates model verdict for ARE is AVOID with an investment score of 34/100. Treat this as a model signal to review, not a personal buy recommendation.